PRIMOBOLAN 100mg/ml

Diseases and conditions requiring high protein production to improve general condition of the patient.

Recovery period. Protein deficiency in old age and chronic liver diseases to support the recovery process and prevent damage from catabolic processes.

Drug interactions:

Primobolan may enhance effects of anitidiabetics,cyclosporin,levothyroxine, warfarin Resistance to the effects of neuromuscular blockers may occur.

Overdosage:

There have been no reports of acute overdosage.

Precautions:

Incase Primobolan is applied during the first days of cycle, menstruation date may delay in women having irregular cycle. Treatment should be ceased in case of hypercalcemia during hormone administration in women with progressive breast and gental carcinomas.

Administration of Primobolan during pregnancy is contraindicated. Transition of methenolone and its metabolites to breast milk is not researched Liver function tests should be clinically monitored regularly. Clinically significant increase in liver function parameters or cholestatic requires Primobolan usage to be ceased. Treatment should be applied by intervals having reasonable gaps of bones in patients who have not completed growth yet.

Dosage and adminstration:

between in order to avoid virilisation symptoms and early development Regular prostate controls are recommended as a precaution. Primobolan is administered by intramuscular injection. It must not be given intravenously. Intramuscular injections should be given deep into the gluteal muscle.

Side effects:

Fluid and electrolyte retention; Psychiatric effects, Hypercalceamia. mpaired glucose tolerance, Increased bone growth and skeletal weight.

Warnings:

Not to be used in animals intended for subsequent breeding, or in dairy animals.

A withdrawal period has not been established for this product in preruminating calves.

Do not use in calves to be processed for veal.

Not for use in humans.

Supplied / storage:

Primobolan is supplied in 5 x1ml ampules. Ampules should be stored at controlled room temperatures below 30˚C and protected from light.
Parenteral drug products should be inspected visually for particulate matter and discolouration prior to administration, whenever solution and container permit.
Warming and shaking the ampules should redisolve any crystals that may have formed during storage al temperature lower than recommended.
If it has expired or is damaged, retum to your pharmacist.

Keep out of the reach and sight of children.